The MADgic® Laryngo-Tracheal Mucosal Atomization Device from Teleflex offers a versatile choice to administer medication* across the entire upper airway and beyond the vocal cords. The MADgic® Device is not prefilled, so the clinician can select the type of medication and exact dosing desired. The malleable stylet enables precise, targeted delivery specific to patient's anatomy.
Consistent, fine atomized spray for direct coverage of nose, pharynx, larynx and trachea
Targeted Coverage – narrow, long stylet easily reaches vocal cords and conforms to patient anatomy
Delivers particles at optimal size for mucosal absorption1
Reduced Cough
In procedures where a cough upon emergence can cause adverse events, application of topical lidocaine on the laryngotracheal region has been shown to provide a smooth emergence from general anesthesia with reduced coughing.2
Patient Comfort
Adequate topical anesthesia has been shown to:
Optimize patient comfort3
Facilitate patient compliance3
*For use with drugs approved for intranasal and oropharyngeal delivery.
References:
Suresh M. Management of Predicted Difficult Airway in A Parturient Undergoing Cesarean Delivery, where Airway Management is Necessary. Shnider and Levinson's Anesthesia for Obstetrics. 2013;(24):381-382.
Diachun CA, Tunink BP, Brock-Utne JG. Suppression of cough during emergence from general anesthesia: laryngotracheal lidocaine through a modified endotracheal tube. J Clin Anesth. 2001 Sep;13(6):447-51.
Leung Y., Vacanti FX. Awake without complaints: maximizing comfort during awake fiberoptic intubation. J Clin Anesth. 2015 Sep;27(6):517-9
Teleflex, the Teleflex logo, MAD, MAD Nasal, MADgic, MADgic Airway and MADomizer are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. MC-001906 Rev 1